Tethering the N-terminus of the prion protein compromises the cellular response to oxidative stress

Journal of Neurochemistry

Volumn 84, Issue 3, 2003, Pages 480-490

  Zeng, Fanning ^a   Watt, Nicole T ^a   Walmsley, Adrian R ^a   Hooper, Nigel M ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Copper; Glutathione peroxidase; Hydrogen peroxide; Oxidative stress; Prion; Superoxide dismutase

Indexed keywords

COPPER; GLUTATHIONE PEROXIDASE; GLYCOSYLPHOSPHATIDYLINOSITOL; HYDROGEN PEROXIDE; PRION PROTEIN; SUPEROXIDE DISMUTASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CELLULAR DISTRIBUTION; ENDOCYTOSIS; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL SURVIVAL; COPPER; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOCYTOSIS; ENDOPEPTIDASE K; FREE RADICALS; GLUTATHIONE PEROXIDASE; HUMANS; HYDROGEN PEROXIDE; MEMBRANE MICRODOMAINS; MICE; NEUROBLASTOMA; OXIDANTS; OXIDATIVE STRESS; PRECIPITIN TESTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SORTING SIGNALS; PRPC PROTEINS; SUPEROXIDE DISMUTASE; TUMOR CELLS, CULTURED;

MURINAE;

EID: 0037316675     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01529.x     Document Type: Article

References (40)

1. Brown D. R. (2001) Prion and prejudice: normal protein and the synapse. Trends Neurosci. 24, 85-90.
2. Brown D. R., Schmidt B. and Kretzschmar H. A. (1997a) Effects of oxidative stress on prion protein expression in PC12 cells. Int. J. Dev. Neurosci. 15, 961-972.
3. Brown D. R., Schulz-Schaeffer W. J., Schmidt B. and Kretzschmar H. A. (1997b) Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp. Neurol. 146, 104-112.
4. Brown D. R., Qin K., Herms J. W., Madlung A., Manson J., Strome R., Fraser P. E., Kruck T., von Bohlen A., Schulz-Schaeffer W., Giese A., Westaway D. and Kretzschmar H. (1997c) The cellular prion protein binds copper in vivo. Nature 390, 684-687.
5. Brown D. R., Schmidt B. and Kretzschmar H. A. (1998) Effects of copper on survival of prion protein knockout neurons and glia. J. Neurochem. 70, 1686-1693.
6. Donne D. G., Viles J. H., Groth D., Mehlhorn I., James T. L., Cohen F. E., Prusiner S. B., Wright P. E. and Dyson H. J. (1997) Structure of the recombinant full-length hamster prion protein PrP (29-231): the N-terminus is highly flexible. Proc. Natl Acad. Sci. USA 94, 13452-13457.
7. Finckh U., Muller-Thomsen T., Mann U., Eggers C., Marksteiner J., Meins W., Binetti G., Alberici A., Hock C., Nitsch R. M. and Gal A. (2000) High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes. Am. J. Hum. Genet. 66, 110-117.
8. Freedman J. H., Ciriolo M. R. and Peisach J. (1989) The role of glutathione in copper metabolism and toxicity. J. Biol. Chem. 264, 5598-5605.
9. Gabus C., Auxilien S., Pechoux C., Dormont D., Swietnicki W., Morillas M., Surewicz W., Nandi P. and Darlix J. L. (2001a) The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein. J. Mol. Biol. 307, 1011-1021.
10. Gabus C., Derrington E., Leblanc P., Chnaiderman J., Dormont D., Swietnicki W., Morillas M., Surewicz W., Marck D., Nandi P. and Darlix J. L. (2001b) The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCp7 of HIV-1. J. Biol. Chem. 276, 19301-19309.
11. Ghetti B., Piccardo P., Spillantini M. G., Ichimiya Y., Porro M., Perini F., Kitamoto T., Tateishi J., Seiler C., Frangione B., Bugiani O., Giaccone G., Prelli F., Goedert M., Dlouhy S. R. and Tagliavini F. (1996) Vascular variant of prion protein cerebral amyloidosis with tau- positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc. Natl Acad. Sci. USA 93, 744-748.
12. Hegde R. S., Mastrianni J. A., Scott M. R., DeFea K. A., Tremblay P., Torchia M., DeArmond S. J., Prusiner S. B. and Lingappa V. R. (1998) A transmembrane form of the prion protein in neurodegenerative disease. Science 279, 827-834.
13. Jaegly A., Mouthon F, Peyrin J. M., Camugli B., Deslys J. P. and Dormont D. (1998) Search for a nuclear localization signal in the prion protein. Mol. Cell. Neurosci. 11, 127-133.
14. Jones K. H. and Senft J. A. (1985) An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide. J. Histochem. Cytochem. 33, 77-79.
15. Kascsak R. J., Rubinstein R., Merz P. A., Tonna-DeMasi M., Fersko R., Carp R. I., Wisniewski H. M. and Diringer H. (1987) Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol. 61, 3688-3693.
16. Kuwahara C., Takeuchi A. M., Nishimura T., Haraguchi K., Kubosaki A., Matsumoto Y., Saeki K., Yokoyama T., Itohara S. and Onodera T. (1999) Prions prevent neuronal cell-line death. Nature 400, 225-226.
17. Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
18. Lawrence R. A. and Burk R. F. (1976) Glutathione peroxidase activity in selenium-deficient rat liver. Biochem. Biophys. Res. Commun. 71, 952-958.
19. LeBel C. P., Ischiropoulos H. and Bondy S. C. (1992) Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 5, 227-231.
20. Lin P. H., Selinfreund R. and Wharton W. (1991) Isolation of cell membrane for epidermal growth factor receptor studies. Methods Enzymol. 198, 251-259.
21. Lorenz H., Windl O. and Kretzschmar H. A. (2002) Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases. J. Biol. Chem. 277, 8508-8516.
22. Sc-like conformation in living cells. Nat. Cell Biol. 1, 358-361.
23. Marklund S. and Marklund G. (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47, 469-474.
24. Milhavet O., McMahon H. E., Rachidi W., Nishida N., Katamine S., Mange A., Arlotto M., Casanova D., Riondel J., Favier A. and Lehmann S. (2000) Prion infection impairs the cellular response to oxidative stress. Proc. Natl Acad. Sci. USA 97, 13937-13942.
25. Miura T., Hori-i. A., Mototani H. and Takeuchi H. (1999) Raman spectroscopic study on the copper (II) binding mode of prion octapeptide and its pH dependence. Biochemistry 38, 11560-11569.
26. Parkin E. T., Hussain I., Turner A. J. and Hooper N. M. (1997) The amyloid precursor protein is not enriched in caveolae-like, detergent-insoluble membrane microdomains. J. Neurochem. 69, 2179-2188.
27. Parkin E. T., Turner A. J. and Hooper N. M. (1999) Amyloid precursor protein, although partially detergent-insoluble in mouse cerebral cortex, behaves as an atypical lipid raft protein. Biochem. J. 344, 23-30.
28. Pauly P. C. and Harris D. A. (1998) Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273, 33107-33110.
29. Perera W. S. S. and Hooper N. M. (1999) Proteolytic fragmentation of the murine prion protein: role of Tyr-128 and His-177. FEBS Lett. 463, 273-276.
30. Perera W. S. S. and Hooper N. M. (2001) Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region. Curr. Biol. 11, 519-523.
31. Prusiner S. B. (1998) Prions. Proc. Natl Acad. Sci. USA 95, 13363-13383.
32. Riek R., Hornemann S., Wider G., Glockshuber R. and Wuthrich K. (1997) NMR characterisation of the full-length recombinant murie prion protein, mPrP (23-231). FEBS Lett. 413, 282-288.
33. Viles J. H., Cohen F. E., Prusiner S. B., Goodin D. B., Wright P. E. and Dyson H. J. (1999) Copper binding to the prion protein: Structural implications of four identical cooperative binding sites. Proc. Natl Acad. Sci. USA 96, 2042-2047.
34. Walmsley A. R., Zeng F. and Hooper N. M. (2001) Membrane topology influences N-glycosylation of the prion protein. EMBO J. 20, 703-712.
35. White A. R., Collins S. J., Maher F., Jobling M. F., Stewart L. R., Thyer J. M., Beyreuther K., Masters C. L. and Cappai R. (1999) Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. Am. J. Pathol. 155, 1723-1730.
36. Whittal R. M., Ball H. L., Cohen F. E., Burlingame A. L., Prusiner S. B. and Baldwin M. A. (2000) Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry. Protein Sci. 9, 332-343.
37. Wong B. S., Liu T., Li R., Pan T., Petersen R. B., Smith M. A., Gambetti P., Perry G., Manson J. C., Brown D. R. and Sy M. S. (2001) Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J. Neurochem. 76, 565-572.
38. Yokoyama T., Kimura K. M., Ushiki Y., Yamada S., Morooka A., Nakashiba T., Sassa T. and Itohara S. (2001) In vivo conversion of cellular prion protein to pathogenic isoforms, as monitored by conformation-specific antibodies. J. Biol. Chem. 276, 11265- 11271.
39. Zahn R., Liu A., Luhrs T, Riek R., von Schroetter C., Lopez Garcia F., Billeter M., Calzolai L., Wider G. and Wuthrich K. (2000) NMR solution structure of the human prion protein. Proc. Natl Acad. Sci. USA 97, 145-150.
40. Zanusso G., Petersen R. B., Jin T., Jing Y., Kanoush R., Ferrari S., Gambetti P. and Singh N. (1999) Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein. J. Biol. Chem. 274, 23396-23404.